Results 151 to 160 of about 44,369 (290)

Drug Critical Limits for Urgent Physician Notification

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 178-192, July 2026.
Critical limits represent quantitative decision thresholds for drugs that require immediate clinician notification and potential life‐saving intervention. United States hospitals lack a national standard for drug critical limits. We collected critical limits from 417 US hospitals across all 50 states and Washington, D.C.; of these, 411 maintained drug ...
Elina Kuang   +3 more
wiley   +1 more source

Prophylactic Dexmedetomidine Reduces Junctional Ectopic Tachycardia and Facilitates Postoperative Recovery in Pediatric Cardiac Surgery: A Systematic Review and Meta‐Analysis of Prospective Trials

open access: yesPediatric Anesthesia, Volume 36, Issue 7, Page 767-777, July 2026.
ABSTRACT Objective To evaluate the efficacy and safety of prophylactic dexmedetomidine in preventing Junctional Ectopic Tachycardia (JET) and its impact on postoperative recovery in pediatric congenital heart surgery, restricting analysis to prospective trials. Methods We systematically searched PubMed, Scopus, and CENTRAL through October 16, 2025, for
Michelle Singh   +5 more
wiley   +1 more source

Longer Baseline Left Ventricular Activation Time Is Associated With Lower Mortality and Lower Risk of Heart Failure Hospitalization in Cardiac Resynchronization Therapy Recipients

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.
In patients undergoing CRT implantation, a longer pre‐implant LVAT was linked to better clinical outcome (lower risk of heart failure hospitalization and all‐cause mortality), suggesting that LVAT may help refine risk stratification after CRT. ABSTRACT Introduction Many patients do not benefit from cardiac resynchronization therapy (CRT) with current ...
Sofia Marinko   +2 more
wiley   +1 more source

The pharmacology and antiarrhythmic actions of RSD 1000

open access: yes, 1995
In an attempt to develop a pathologically-specific antiarrhythmic agent, a series of arylacetamide derivatives have been synthesized. One of these compounds, RSD 1000 is very efficacious against arrhythmias produced during myocardial ischaemia and ...
Yong, Sandro Luis
core  

Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?

open access: yes
The Journal of Physiology, EarlyView.
Jean‐Pierre Benitah   +2 more
wiley   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5767-5778, July 2026.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström   +10 more
wiley   +1 more source

Sildenafil helps the beat go on

open access: yesExperimental Physiology
Jules C. Hancox
doaj   +1 more source

Home - About - Disclaimer - Privacy